| 5.8 |
17.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 4.7 |
18.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 4.7 |
14.0 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 4.4 |
13.1 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 4.0 |
15.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 3.8 |
11.5 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 3.7 |
14.9 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 3.6 |
14.4 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 3.6 |
14.3 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 3.5 |
14.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 3.3 |
9.9 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 3.2 |
22.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 3.1 |
3.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 3.0 |
14.8 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 2.9 |
17.5 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.8 |
5.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.8 |
8.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.7 |
30.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 2.7 |
13.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 2.7 |
8.0 |
GO:1902287 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 2.6 |
7.8 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.5 |
2.5 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 2.5 |
9.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.4 |
9.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 2.4 |
16.5 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 2.3 |
6.8 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.2 |
21.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 2.2 |
15.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.1 |
6.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 2.1 |
6.4 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 2.1 |
4.2 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.1 |
8.4 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 2.1 |
29.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 2.1 |
4.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 2.1 |
32.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 2.0 |
6.1 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 2.0 |
6.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.9 |
7.8 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.9 |
5.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.9 |
3.9 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 1.9 |
13.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.9 |
9.6 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 1.9 |
3.8 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 1.9 |
5.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.9 |
5.6 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.8 |
12.9 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.8 |
16.6 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 1.8 |
10.9 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.8 |
18.1 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 1.8 |
1.8 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.8 |
7.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.8 |
5.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.7 |
1.7 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.7 |
5.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 1.7 |
8.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.7 |
10.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 1.7 |
1.7 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.7 |
10.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.7 |
8.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.6 |
13.0 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 1.6 |
6.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.6 |
4.9 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.6 |
1.6 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 1.6 |
4.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.6 |
4.8 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.6 |
7.9 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 1.6 |
4.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.6 |
4.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.6 |
7.9 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 1.6 |
11.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.6 |
4.7 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.6 |
4.7 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.6 |
10.9 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.6 |
4.7 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 1.5 |
1.5 |
GO:0086029 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 1.5 |
4.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.5 |
4.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.5 |
3.0 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 1.5 |
6.0 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 1.5 |
3.0 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 1.5 |
3.0 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 1.5 |
7.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 1.5 |
14.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.4 |
5.8 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.4 |
10.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.4 |
4.3 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.4 |
4.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 1.4 |
4.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.4 |
5.6 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.4 |
6.9 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.4 |
4.1 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 1.3 |
20.1 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 1.3 |
4.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.3 |
4.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.3 |
5.3 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.3 |
5.3 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.3 |
6.6 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 1.3 |
7.9 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) |
| 1.3 |
2.6 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 1.3 |
5.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.3 |
3.8 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.3 |
3.8 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.3 |
10.2 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.2 |
2.5 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 1.2 |
8.7 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.2 |
1.2 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 1.2 |
1.2 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 1.2 |
3.6 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.2 |
7.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.2 |
2.4 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.2 |
3.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.2 |
3.6 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 1.2 |
3.6 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 1.2 |
9.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 1.2 |
28.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.2 |
2.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.2 |
3.5 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.2 |
8.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.2 |
3.5 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.2 |
3.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.1 |
3.4 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.1 |
5.7 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 1.1 |
6.8 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 1.1 |
1.1 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 1.1 |
7.9 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 1.1 |
6.7 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.1 |
4.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.1 |
1.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 1.1 |
4.3 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.1 |
3.2 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.1 |
10.7 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.1 |
4.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.1 |
3.2 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 1.0 |
4.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.0 |
1.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.0 |
4.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.0 |
9.3 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.0 |
4.0 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 1.0 |
6.0 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 1.0 |
1.0 |
GO:0099548 |
trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
| 1.0 |
5.0 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.0 |
10.0 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.0 |
3.0 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.0 |
3.0 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.0 |
4.9 |
GO:1904908 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.0 |
1.0 |
GO:1900141 |
regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
| 1.0 |
1.0 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.0 |
2.9 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 1.0 |
1.0 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.0 |
23.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 1.0 |
1.9 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.0 |
1.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.9 |
1.9 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.9 |
2.8 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.9 |
6.6 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.9 |
4.7 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.9 |
2.8 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.9 |
11.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.9 |
2.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
0.9 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.9 |
2.8 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.9 |
0.9 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.9 |
4.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.9 |
2.7 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.9 |
2.7 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.9 |
4.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.9 |
1.8 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.9 |
4.5 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.9 |
3.6 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.9 |
6.3 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.9 |
2.7 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.9 |
2.7 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.9 |
2.7 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.9 |
15.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.9 |
2.6 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.9 |
1.8 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.9 |
2.6 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.9 |
13.9 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.9 |
10.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.9 |
1.7 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.9 |
2.6 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.8 |
7.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.8 |
3.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.8 |
7.6 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) |
| 0.8 |
2.5 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.8 |
2.5 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 0.8 |
0.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.8 |
0.8 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.8 |
5.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.8 |
0.8 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.8 |
2.5 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.8 |
5.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.8 |
1.6 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.8 |
2.4 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 |
2.4 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.8 |
0.8 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.8 |
1.6 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 |
4.7 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.8 |
7.1 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.8 |
3.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.8 |
3.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.8 |
1.6 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.8 |
8.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.8 |
0.8 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.8 |
3.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 |
1.5 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.8 |
6.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.8 |
2.3 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) positive regulation of female receptivity(GO:0045925) |
| 0.8 |
5.3 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.8 |
0.8 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.8 |
0.8 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.8 |
0.8 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.8 |
2.3 |
GO:1901166 |
neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.8 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.8 |
0.8 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.8 |
5.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.7 |
9.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.7 |
3.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.7 |
2.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.7 |
5.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.7 |
3.7 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.7 |
2.2 |
GO:0070650 |
actin filament bundle distribution(GO:0070650) |
| 0.7 |
1.4 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.7 |
5.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.7 |
2.2 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.7 |
2.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.7 |
5.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.7 |
2.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.7 |
2.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.7 |
2.1 |
GO:2000836 |
positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
| 0.7 |
2.1 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.7 |
2.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.7 |
2.8 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.7 |
7.6 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.7 |
1.4 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.7 |
4.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.7 |
4.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.7 |
2.1 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.7 |
2.1 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 |
2.0 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.7 |
2.7 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.7 |
2.7 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.7 |
3.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 |
2.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.7 |
2.0 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.7 |
4.0 |
GO:1903624 |
regulation of DNA catabolic process(GO:1903624) |
| 0.7 |
2.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 |
0.7 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 0.7 |
3.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.7 |
2.0 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.7 |
4.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.7 |
3.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.7 |
3.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 |
3.3 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.7 |
3.9 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.7 |
9.8 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.7 |
3.3 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.6 |
2.6 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.6 |
7.8 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.6 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.6 |
1.9 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.6 |
7.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 |
9.0 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.6 |
3.2 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.6 |
1.3 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.6 |
3.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.6 |
2.5 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.6 |
2.5 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.6 |
2.5 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.6 |
1.9 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.6 |
1.9 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.6 |
0.6 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.6 |
0.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.6 |
10.6 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
7.5 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.6 |
1.9 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.6 |
1.9 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.6 |
4.9 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.6 |
2.5 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.6 |
1.9 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.6 |
1.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.6 |
0.6 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.6 |
0.6 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
12.1 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.6 |
1.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.6 |
1.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 |
2.4 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
| 0.6 |
2.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.6 |
2.4 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.6 |
10.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 |
4.2 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.6 |
1.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.6 |
7.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.6 |
2.4 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.6 |
0.6 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.6 |
1.8 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.6 |
3.5 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
4.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.6 |
1.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.6 |
4.6 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.6 |
1.7 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.6 |
2.3 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.6 |
2.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.6 |
2.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.6 |
1.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.6 |
6.3 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.6 |
1.7 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.6 |
5.1 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.6 |
7.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.6 |
1.7 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.6 |
3.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.6 |
2.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
1.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.6 |
2.2 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.6 |
1.7 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.6 |
1.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.6 |
2.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.6 |
1.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.6 |
6.1 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.5 |
2.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 |
0.5 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.5 |
1.1 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.5 |
2.7 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.5 |
1.1 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.5 |
4.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.5 |
4.9 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.5 |
0.5 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.5 |
4.3 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
2.7 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.5 |
2.7 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.5 |
0.5 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.5 |
2.1 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.5 |
1.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.5 |
2.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.5 |
2.6 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.5 |
0.5 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.5 |
2.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.5 |
1.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.5 |
5.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.5 |
1.6 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.5 |
2.6 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.5 |
4.1 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.5 |
0.5 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.5 |
1.0 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.5 |
6.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 |
1.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 |
0.5 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.5 |
1.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.5 |
4.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.5 |
2.0 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.5 |
2.0 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.5 |
8.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.5 |
2.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 |
1.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
2.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 |
0.5 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
3.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 |
1.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.5 |
1.5 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.5 |
3.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.5 |
1.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
1.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
1.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 |
1.5 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
4.4 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.5 |
5.4 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) |
| 0.5 |
2.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.5 |
1.0 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.5 |
1.5 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.5 |
0.5 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.5 |
1.5 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.5 |
2.4 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 |
0.5 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
3.4 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.5 |
4.3 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.5 |
0.5 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.5 |
1.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.5 |
1.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.5 |
0.9 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.5 |
0.9 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.5 |
1.9 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.5 |
7.9 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.5 |
1.4 |
GO:0002265 |
astrocyte activation involved in immune response(GO:0002265) |
| 0.5 |
0.9 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) |
| 0.5 |
3.2 |
GO:0098885 |
modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.5 |
1.4 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.5 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 |
0.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.5 |
1.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 |
1.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.5 |
4.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.5 |
1.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.5 |
0.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.5 |
3.6 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.5 |
2.3 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
4.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.5 |
0.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 |
0.9 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 |
4.5 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
3.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 |
1.8 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.4 |
3.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 |
0.4 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.4 |
2.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 |
0.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 |
2.2 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 |
1.8 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.4 |
4.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 |
0.9 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.4 |
3.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.4 |
0.9 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.4 |
0.9 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 |
1.7 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.4 |
1.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.4 |
1.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.4 |
1.3 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.4 |
2.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.4 |
0.9 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.4 |
1.3 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 |
4.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.4 |
0.4 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.4 |
1.3 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.4 |
1.7 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
2.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
0.4 |
GO:1905066 |
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) regulation of heart induction(GO:0090381) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.4 |
3.0 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 |
1.3 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.4 |
1.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 |
0.4 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.4 |
2.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.4 |
1.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 |
0.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
1.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.4 |
1.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.4 |
3.3 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.4 |
0.4 |
GO:0072071 |
kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) |
| 0.4 |
5.8 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.4 |
0.8 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
0.8 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.4 |
1.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
3.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 |
1.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 |
0.4 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.4 |
2.8 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.4 |
1.2 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.4 |
2.8 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.4 |
4.9 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.4 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
1.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
8.0 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.4 |
0.4 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.4 |
1.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 |
0.4 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.4 |
0.8 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.4 |
1.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
3.1 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.4 |
3.5 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.4 |
0.8 |
GO:0072103 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.4 |
0.4 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.4 |
0.4 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.4 |
3.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.4 |
1.9 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.4 |
3.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 |
1.9 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.4 |
0.4 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.4 |
1.9 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.4 |
1.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.4 |
4.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
6.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.4 |
1.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 |
0.8 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.4 |
0.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.4 |
2.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.4 |
1.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.4 |
3.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.4 |
2.6 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.4 |
1.1 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.4 |
2.6 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.4 |
0.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.4 |
5.5 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.4 |
0.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.4 |
0.7 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
3.3 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.4 |
1.5 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.4 |
0.4 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.4 |
2.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.4 |
0.7 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.4 |
2.5 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.4 |
0.7 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.4 |
1.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 |
0.7 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 |
2.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 |
1.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.4 |
2.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.4 |
1.1 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.4 |
1.1 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 0.4 |
0.7 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
0.4 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.4 |
1.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.4 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 |
1.7 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
2.8 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
1.0 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 |
5.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
1.0 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 |
1.0 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.3 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 |
1.0 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.3 |
1.4 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.3 |
2.0 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.3 |
2.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
0.7 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
5.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.3 |
0.7 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.3 |
0.7 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.3 |
2.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.3 |
0.7 |
GO:1903392 |
negative regulation of adherens junction organization(GO:1903392) |
| 0.3 |
2.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 |
1.3 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.3 |
2.0 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.3 |
1.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
3.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
1.0 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.3 |
0.7 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
2.0 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.3 |
0.7 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.3 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.3 |
4.6 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.3 |
1.9 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 |
2.6 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.3 |
2.9 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.3 |
1.3 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
3.5 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.3 |
2.2 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.3 |
2.2 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.3 |
0.9 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
2.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.3 |
8.8 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.3 |
2.8 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 |
0.9 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.3 |
1.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
1.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
6.8 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.3 |
2.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
1.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.3 |
4.9 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.3 |
0.9 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.3 |
1.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.6 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.3 |
7.0 |
GO:0034661 |
ncRNA catabolic process(GO:0034661) |
| 0.3 |
0.9 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.3 |
1.5 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.3 |
4.2 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.3 |
2.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 |
0.3 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 |
0.9 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.3 |
1.2 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 |
1.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 |
0.9 |
GO:0060903 |
regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
| 0.3 |
2.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.3 |
1.8 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
0.9 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
1.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 |
0.3 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.3 |
2.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 |
0.3 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
0.9 |
GO:1904479 |
urate transport(GO:0015747) negative regulation of intestinal absorption(GO:1904479) |
| 0.3 |
6.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 |
2.0 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.3 |
0.9 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.3 |
0.9 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.3 |
3.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
0.9 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
0.9 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.3 |
1.1 |
GO:1903300 |
regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
1.7 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.3 |
0.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.3 |
0.8 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 |
1.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
3.9 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.3 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
1.7 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.3 |
0.3 |
GO:0099628 |
receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 0.3 |
3.1 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.3 |
1.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.3 |
0.6 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.3 |
2.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.3 |
1.4 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
0.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
0.8 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 |
3.0 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.3 |
1.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 |
1.9 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 |
3.8 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.3 |
7.3 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.3 |
1.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
0.5 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.3 |
25.3 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
0.8 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.3 |
0.5 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.3 |
1.6 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
1.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
3.9 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 |
0.5 |
GO:1900117 |
regulation of execution phase of apoptosis(GO:1900117) |
| 0.3 |
4.7 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.3 |
0.3 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.3 |
2.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
1.5 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
1.8 |
GO:0051351 |
positive regulation of ligase activity(GO:0051351) |
| 0.3 |
1.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.3 |
3.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
0.8 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.3 |
0.8 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
0.8 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 |
0.5 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.3 |
1.0 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 |
2.0 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 |
1.5 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 |
2.7 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
1.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
6.9 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
0.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
1.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.2 |
1.2 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 |
1.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 |
0.2 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
3.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
1.9 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.2 |
1.0 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
3.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
1.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
2.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
0.7 |
GO:0048631 |
skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 |
1.7 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.2 |
0.7 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
0.9 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 |
0.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
0.9 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
0.7 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.2 |
0.7 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.2 |
0.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.2 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
4.9 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.2 |
2.1 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.2 |
0.5 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.2 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 |
0.9 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
0.7 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
5.4 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.2 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
2.5 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.2 |
2.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.9 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
0.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
2.5 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
0.7 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
4.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.2 |
0.4 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 |
0.9 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
1.1 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 |
1.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.2 |
1.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.2 |
0.9 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.2 |
0.4 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.2 |
0.7 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.2 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
0.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
2.6 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.2 |
1.1 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.2 |
0.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
1.5 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
0.9 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.2 |
3.2 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.2 |
0.9 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
1.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
0.4 |
GO:0042117 |
monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.6 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
0.6 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.2 |
0.8 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.2 |
1.5 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.2 |
3.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 |
0.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.2 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
0.6 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 |
0.6 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
1.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
1.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.6 |
GO:0051208 |
sequestering of calcium ion(GO:0051208) regulation of sequestering of calcium ion(GO:0051282) |
| 0.2 |
1.0 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
3.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.6 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.8 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
0.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
0.4 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.2 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
1.8 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 |
1.0 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
0.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
0.6 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
1.0 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.2 |
0.8 |
GO:0046850 |
regulation of bone remodeling(GO:0046850) |
| 0.2 |
2.8 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.2 |
0.2 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 |
1.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.2 |
0.6 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 |
4.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.2 |
8.5 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.2 |
0.8 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
0.4 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.2 |
0.6 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 |
0.4 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
1.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
1.6 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
25.6 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
1.2 |
GO:1901911 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 |
0.6 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.2 |
0.2 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
2.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.2 |
0.4 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.2 |
1.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
0.2 |
GO:0016554 |
base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.2 |
2.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.2 |
10.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.2 |
0.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.8 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
1.7 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 |
2.3 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.2 |
0.8 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
1.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.2 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.2 |
0.4 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
1.7 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 |
0.6 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.2 |
0.7 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 |
0.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
1.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.6 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.2 |
0.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
1.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.7 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.2 |
1.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
2.2 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.2 |
1.1 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.2 |
0.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
1.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
0.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
0.5 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.7 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.2 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.2 |
0.5 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
1.9 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.2 |
0.9 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
0.2 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.2 |
0.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.2 |
0.5 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.2 |
0.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
2.6 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
1.2 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.2 |
0.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
0.2 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 |
0.2 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 |
1.4 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.2 |
0.3 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
0.5 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.2 |
1.7 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
0.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
0.2 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 |
1.7 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
1.5 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
0.7 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
0.5 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
1.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
1.0 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.2 |
0.2 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.2 |
0.7 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.2 |
0.5 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 |
1.7 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.2 |
0.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
10.2 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.2 |
1.0 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
1.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
2.9 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.2 |
0.6 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.2 |
0.2 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 |
0.8 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.2 |
0.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
0.3 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.2 |
1.0 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
1.9 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
2.1 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
6.6 |
GO:1903317 |
regulation of protein maturation(GO:1903317) |
| 0.2 |
0.2 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.2 |
0.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.2 |
0.3 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.8 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.2 |
3.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.3 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
2.0 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
1.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 |
1.1 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.2 |
0.2 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.1 |
0.4 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.4 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 |
0.3 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.4 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.7 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.1 |
1.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
1.9 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
1.7 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.4 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.0 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.9 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.4 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
0.1 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 |
0.1 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 |
0.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.7 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
1.3 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.1 |
4.3 |
GO:0019226 |
transmission of nerve impulse(GO:0019226) |
| 0.1 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.4 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.3 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
1.9 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 |
0.4 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 |
0.3 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 |
1.3 |
GO:0010771 |
negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
| 0.1 |
0.3 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.3 |
GO:0050685 |
positive regulation of mRNA processing(GO:0050685) |
| 0.1 |
0.1 |
GO:1904959 |
regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
8.2 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.5 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.5 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.1 |
GO:0060534 |
trachea cartilage development(GO:0060534) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.9 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.1 |
0.9 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.6 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.5 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.7 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 |
0.4 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.7 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.5 |
GO:1903028 |
asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.1 |
0.5 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.1 |
1.4 |
GO:0051058 |
negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
1.2 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.1 |
0.1 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.1 |
0.7 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.2 |
GO:0060384 |
innervation(GO:0060384) |
| 0.1 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.8 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.1 |
1.2 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.2 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.1 |
0.2 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.7 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.5 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
2.4 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.2 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.2 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.1 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.8 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.4 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
1.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.5 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
4.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.8 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.1 |
0.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.1 |
0.7 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.3 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.1 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
0.2 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.6 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.6 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.1 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.1 |
0.1 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.8 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.1 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
0.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.4 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 |
0.4 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.1 |
1.6 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.4 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.1 |
1.0 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
2.2 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
2.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
0.3 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.1 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.1 |
2.6 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
2.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.9 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.3 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
1.9 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 |
0.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
1.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.4 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
1.0 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
0.4 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 |
0.3 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
6.8 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.8 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
1.8 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.1 |
1.8 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.3 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.1 |
1.0 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 |
0.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.1 |
GO:0039692 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 |
0.2 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
0.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
2.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
2.9 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.1 |
1.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.3 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
0.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.3 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.6 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.4 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.1 |
GO:0043455 |
regulation of secondary metabolic process(GO:0043455) |
| 0.1 |
0.5 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.1 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
0.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.6 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.6 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.1 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.7 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.3 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.5 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.1 |
0.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
2.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.7 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.1 |
0.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.3 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.3 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
0.2 |
GO:1901631 |
positive regulation of presynaptic membrane organization(GO:1901631) |
| 0.1 |
0.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.3 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.1 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.2 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
1.6 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.1 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.1 |
0.6 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
1.1 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
0.2 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.6 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.8 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
1.5 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.1 |
0.3 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.2 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 |
1.0 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.3 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.1 |
0.2 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
1.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.1 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.4 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
0.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.4 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.5 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.0 |
2.0 |
GO:0042384 |
cilium assembly(GO:0042384) |
| 0.0 |
0.0 |
GO:0034331 |
cell junction maintenance(GO:0034331) |
| 0.0 |
0.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.0 |
0.2 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.0 |
0.1 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.0 |
0.2 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.0 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.0 |
0.1 |
GO:2000407 |
T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.0 |
0.6 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.2 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.0 |
0.1 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 |
0.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.7 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.0 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
0.3 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.6 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.0 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
1.7 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.1 |
GO:0043303 |
mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.3 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.2 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 |
0.3 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.2 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.1 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.0 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
| 0.0 |
0.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
0.2 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.3 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.0 |
0.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 |
0.1 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.0 |
0.1 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.0 |
0.1 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.0 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.0 |
0.1 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.2 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.0 |
0.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.0 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 |
0.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.2 |
GO:0002221 |
pattern recognition receptor signaling pathway(GO:0002221) innate immune response-activating signal transduction(GO:0002758) |
| 0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.0 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.0 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.0 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.0 |
0.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.0 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.0 |
0.0 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.2 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.0 |
0.0 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.1 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.1 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.0 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.0 |
GO:0002886 |
regulation of myeloid leukocyte mediated immunity(GO:0002886) |
| 0.0 |
0.0 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 |
0.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.0 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.0 |
0.1 |
GO:0072599 |
establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 |
0.0 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.2 |
GO:1904353 |
regulation of telomere capping(GO:1904353) |
| 0.0 |
0.0 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.0 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
0.0 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.0 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.0 |
0.0 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
